KATHLEEN SELHORST: Open Payments
NPI 1861475238 · LEIPSIC, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$773 in 41 payments from 6 companies in 2025. Trend: 2023 $151 · 2024 $314 · 2025 $773
Food & beverage: $773
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $291 |
| ABBVIE INC. | 17 | $267 |
| Dexcom, Inc. | 3 | $155 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| PFIZER INC. | 1 | $14 |
Products named: Ozempic, QULIPTA, DEXCOM G7 GSS (161), UBRELVY, GEMTESA, Dexcom G6 Transmitter, TRELEGY ELLIPTA, NURTEC ODT.
Industry payments across OH — which companies pay providers there.
